Trial Profile
Phase III trial of bucindolol in patients with chronic heart failure selected based on genotype.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2013
Price :
$35
*
At a glance
- Drugs Bucindolol (Primary) ; Metoprolol succinate
- Indications Chronic heart failure
- Focus Pharmacogenomic; Registrational; Therapeutic Use
- Sponsors ARCA biopharma Inc
- 24 Nov 2009 New trial record.